New analysis finds more than half of U.S. adolescents and young adults with sarcoma—a type of cancer in the bones or soft tissues—are often prescribed opioids to treat their pain.
National Comprehensive Cancer Network honors oncology leaders: Robert Winn, MD, and Shonta Chambers, MSW, named joint Partners in Cancer Care; William Gradishar, MD, named Rodger Winn Award recipient for work on NCCN Guidelines; Hema Sundar, PhD, named Employee of the Year.
Shlomo Melmed, MB, ChB, a world-renowned leader in pituitary medicine, was named the inaugural recipient of the Transatlantic Alliance Award by the European Society of Endocrinology (ESE) and the Endocrine Society for his pioneering research in pituitary medicine and endocrine tumors.
A comprehensive assessment of the benefits of medical cannabis for cancer-related pain found that for most oncology patients, pain measures improved significantly, other cancer-related symptoms also decreased, the consumption of painkillers was reduced, and the side effects were minimal.
Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.
Research to Prevent Blindness and Castle Biosciences today announced that they are partnering to increase opportunities for medical students to gain research experiences, specifically in the field of ocular cancer.
Studies have shown that the way LGBTQ+ patients are screened, diagnosed and treated for cancer may put them at a significant disadvantage compared to cisgender heterosexual patients.
Curtin University researchers will examine if the long-term use of a popular blood pressure medication increased the risk of breast cancer in almost 200,000 women as part of a new project supported by the Federal Government.
A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators say.
Intravesical chemotherapy, is specifically for patients with recurrent non-muscle bladder cancers that aren’t responding to BCG. Up to 50 percent of patients respond to this therapy, helping them avoid major surgery.
The National Cancer Institute-designated Montefiore Einstein Cancer Center (MECC) has partnered with the Price Family Foundation to fund eight research teams developing novel cancer therapies and improving cancer outcomes for historically marginalized communities in the Bronx.
Cancer health disparities are often identified from population-based surveillance data routinely captured by statewide cancer registries. Antoinette Stroup, PhD, of Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute – Designated Comprehensive Cancer Center together with RWJBarnabas Health and Rutgers School of Public Health is the director of the New Jersey State Cancer Registry (NJSCR), explores cancer and health data on the Asian American and Pacific Islander population.
Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.
Pioneering breast cancer surgeon, clinician and researcher Armando E. Giuliano, MD-who helped introduce sentinel lymph node biopsy in the early 1990s, sparing many women the need for major breast cancer surgery-has been named regional medical director of the Cedars-Sinai Cancer Breast Oncology Program.
Reminders from a romantic partner might be an effective way to encourage sunscreen use by people age 50 or older, suggests a study in the May/June issue of The Journal of the Dermatology Nurses' Association, official publication of the Dermatology Nurses' Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.
A new surgical robotic system is "feasible, safe, and effective" for treatment of early-stage prostate cancer, concludes an initial evaluation in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Showing results
1–20 of 20918
RSS Feeds by Section